No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | ACKIU | Ackrell SPAC Partners I Co. | Rating: Outperform | $14 | 06-13-2022 | View Chart |
2 | AGIL | AgileThought | Rating: Buy | $8 | 06-13-2022 | View Chart |
3 | EQRX | EQRx | Rating: Buy | $8 | 06-13-2022 | View Chart |
4 | MNSO | Miniso Group | Rating: Buy | $-- | 06-13-2022 | View Chart |
5 | RANI | Rani Therapeutics | Rating: Outperform | $28 | 06-13-2022 | View Chart |
6 | SI | Silvergate Capital | Rating: Overweight | $120 | 06-13-2022 | View Chart |
7 | STRY | Starry | Rating: Buy | $11 | 06-13-2022 | View Chart |
No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | BHC | Bausch Health | Rating: Overweight | $12 | 06-13-2022 | View Chart |
2 | BMRN | BioMarin Pharm | Rating: Neutral | $146>>70 | 06-13-2022 | View Chart |
3 | FMTX | Forma Therapeutics | Rating: Overweight | $46>>21 | 06-13-2022 | View Chart |
4 | SGMO | Sangamo Therapeutics | Rating: Neutral | $5 | 06-13-2022 | View Chart |
No. | Symbol | Company | Analyst Recommendation / Rating Change | Date | Chart |
---|---|---|---|---|---|
None |